Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Faraz Ali

CEO at Tenaya Therapeutics, Inc. (TNYA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $32K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 17SEC TNYATenaya Therapeutics, Inc. Sell 5,837434,177 held (−1%) $0.71 $4K -18.3%
Aug 17SEC TNYATenaya Therapeutics, Inc. Sell 3,969430,208 held (−1%) $0.71 $3K -18.3%
Aug 17SEC TNYATenaya Therapeutics, Inc. Sell 5,020425,188 held (−1%) $0.71 $4K -18.3%
Aug 17SEC TNYATenaya Therapeutics, Inc. Sell 7,406417,782 held (−2%) $0.71 $5K -18.3%
May 19SEC TNYATenaya Therapeutics, Inc. Sell 3,390440,014 held (−1%) $0.79 $3K -26.6%
Feb 17SEC TNYATenaya Therapeutics, Inc. Sell 5,851452,415 held (−1%) $0.64 $4K -9.4%
Feb 17SEC TNYATenaya Therapeutics, Inc. Sell 3,979448,436 held (−1%) $0.64 $3K -9.4%
Feb 17SEC TNYATenaya Therapeutics, Inc. Sell 5,032443,404 held (−1%) $0.64 $3K -9.4%
Nov 17SEC TNYATenaya Therapeutics, Inc. Sell 3,126299,666 held (−1%) $1.33 $4K -56.4%